Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas

Journal of Oral Pathology and Medicine

Volumn 38, Issue 4, 2009, Pages 377-385

  Maruyama, Satoshi ^a   Cheng, Jun ^a   Yamazaki, Manabu ^a   Liu, Airu ^b   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Capsular invasion; Keratinocyte growth factor; Pleomorphic adenoma; Salivary gland; Vascular involvement

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; PERLECAN;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SALIVARY GLAND TUMOR; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

ADENOMA, PLEOMORPHIC; BLOOD VESSELS; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 7; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 62949221903     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00742.x     Document Type: Article

References (45)

1. Waldron CA. Mixed tumor (pleomorphic adenoma) and myoepithelioma. In : Ellis GL, Auclair PL, Gnepp DR, eds Surgical Pathology of the Salivary Glands. Philadelphia : W. B. Saunders Co, 1991 165 86.
2. Ellis GL, Auclair PL. Tumors of the Salivary glands: Atlas of Tumor Pathology, 3rd Series. Washington, DC : Armed Forces Institute of Pathology, 1996 39 57.
3. Hickman RE, Cawson RA, Duffy SW. The prognosis of specific types of salivary gland tumors. Cancer 1984 54 : 1620 4.
4. Batsakis JG, Regezi JA, Bioch D. The pathology of head and neck tumors: salivary glands, part3. Head Neck Surg 1979 1 : 260 73.
5. Stennert E, Guntinas-Lichius O, Klussmann JP, Arnold G. Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases. Laryngoscope 2001 111 : 2195 200.
6. Gnepp DR, Wenig BM. Malignant mixed tumors. In : Ellis GL, Auclair PL, Gnepp DR, eds Surgical Pathology of the Salivary Glands. Philadelphia : W. B. Saunders Co, 1991 350 68.
7. Ellis GL, Auclair PL. Tumors of the Salivary glands: Atlas of Tumor Pathology, 3rd Series. Washington, DC : Armed Forces Institute of Pathology, 1996 228 38.
8. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993 28 : 279 328.
9. LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign tumors: a clinicopathologic study. Cancer 1977 39 : 2209 30.
10. Ohtaké S, Cheng J, Ida H, et al. Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med 2002 31 : 590 7.
11. Ryan RE Jr., DeSanto LW, Weiland LH, Devine KD, Beahrs OH. Cellular mixed tumors of the salivary glands. Arch Otolaryngol 1978 104 : 451 3.
12. Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 81 : 655 64.
13. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol 1996 9 : 652 7.
14. Takeda Y. An immunohistochemical study of bizarre neoplastic cells in pleomorphic adenoma: its cytological nature and proliferative activity. Pathol Int 1999 49 : 993 9.
15. Rodríguez-Fernández J, Mateos-Micas M, Martínez- Tello FJ, et al. Metastatic benign pleomorphic adenoma. Report of a case and review of the literature. Med Oral Patol Oral Cir Bucal 2008 13 : E193 6.
16. Chau MN, Radden BG. A clinical-pathological study of 53 intra-oral pleomorphic adenomas. Int J Oral Maxillofac Surg 1989 18 : 158 62.
17. Zbären P, Stauffer E. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors. Head Neck 2007 29 : 751 7.
18. Maran AG, Mackenzie IJ, Stanley RE. Recurrent pleomorphic adenomas of the parotid gland. Arch Otolaryngol 1984 110 : 167 71.
19. Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol 1995 104 : 100 4.
20. Leverstein H, van der Wal JE, Tiwari RM, van der Waal I, Snow GB. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 1997 84 : 399 403.
21. Henriksson G, Westrin KM, Carlsöö B, Silfverswärd C. Recurrent primary pleomorphic adenoma of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer 1998 82 : 617 20.
22. Laskawi R, Schott T, Schröder M. Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg 1998 36 : 48 51.
23. Carew JF, Spiro RH, Singh B, Shah JP. Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol Head Neck Surg 1999 121 : 539 42.
24. Glas AS, Vermey A, Hollema H, et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients. Head Neck 2001 23 : 311 6.
25. Saku T, Cheng J, Okabe H, Koyama Z. Immunolocalization of basement membrane molecules in the stroma of salivary gland pleomorphic adenoma. J Oral Pathol Med 1990 19 : 208 14.
26. Cheng J, Saku T, Okabe H, Furthmayer H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer 1992 69 : 2631 40.
27. Ida-Yonemochi H, Ikarashi T, Nagata M, Hoshina H, Takagi R, Saku T. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch 2002 441 : 165 73.
28. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996 271 : 10079 86.
29. Mongiat M, Taylor K, otto J, et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem 2000 275 : 7095 100.
30. Saku T, Okabe H, Yagi Y, Sato E, Tsuda N. A comparative study on the immunolocalization of keratin and myosin in salivary gland tumors. Acta Pathol Jpn 1984 34 : 1031 40.
31. Metwaly H, Cheng J, Ida-Yonemochi H, et al. Vascular endothelial cell participation in formation of lymphoepithelial lesions (epi-myoepithelial islands) in lymphoepithelial sialadenitis (benign lymphoepithelial lesion). Virchows Arch 2003 443 : 17 27.
32. Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T. Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 2005 446 : 653 62.
33. Kimura S, Cheng J, Toyoshima K, Oda K, Saku T. Basement membrane heparan sulfate proteoglycan (perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. J Biochem 1999 125 : 406 13.
34. Ito M, Izumi N, Cheng J, et al. Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas. J Oral Pathol Med 2003 32 : 10 7.
35. Sabit H, Tsuneyama K, Shimonishi T, et al. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Pathol Int 2001 51 : 248 56.
36. Sher I, Lang T, Lubinsky-Mink S, et al. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7. J Biol Chem 2000 275 : 34881 6.
37. Thomas KM, Hutt MS, Borgstein J. Salivary gland tumor in Malawi. Cancer 1980 46 : 2328 34.
38. Altini M, Coleman H, Kienle F. Intra-vascular tumor in pleomorphic adenoma - a report of four cases. Histopathology 1997 31 : 55 9.
39. Coleman H, Altini M. Intravascular tumor in intra-oral pleomorphic adenomas: a diagnostic and therapeutic dilemma. Histopathology 1999 35 : 439 44.
40. Morrison PD, McMullin JP. A case of metastasizing benign pleomorphic adeoma of the parotid. Clin Oncol 1984 10 : 173 6.
41. el-Naggar A, Batsakis JG, Kessler S. Benign metastatic mixed tumours or unrecognized salivary carcinomas? J Laryngol Otol 1988 102 : 810 2.
42. Pitman MB, Thor AD, Goodman ML, Rosenberg AE. Benign metastasizing pleomorphic adenoma of salivary gland: diagnosis of bone lesions by fine-needle aspiration biopsy. Diagn Cytopathol 1992 8 : 384 7.
43. Schreibstein JM, Tronic B, Tarlov E, Hybels RL. Benign metastasizing pleomorphic adenoma. Otolaryngol Head Neck Surg 1995 112 : 612 5.
44. Hoorweg JJ, Hilgers FJ, Keus RB, Zoetmulder FA, Loftus BM. Metastasizing pleomorphic adenoma; a report of three cases. Eur J Surg Oncol 1998 24 : 452 5.
45. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982 30 : 107 12.